W
e investigated the enhancement of gene transfer across epithelial cells using adenoviral vectors by the addition of low doses of ethylene glycol-bis(␤-aminoethylether)-N,N,NЈ,NЈ-tetra-acetic acid (EGTA). In the first series of experiments, we instilled intratracheally in CD-1 mice 10 8 plaque-forming units of adenoviral vector-containing reporter genes with and without 100 M EGTA. Significant expression of luciferase was found in lung tissue 7 days later; addition of 100 M EGTA in the instillate increased adenoviral luciferase expression by 600%.
To identify potential mechanisms by which EGTA increased gene transfer, we infected nonconfluent monolayers of A549, fetal distal lung epithelial cells, and primary human airway epithelial cells with adenoviral vectors containing LacZ in the presence or absence of 100 M EGTA. Significantly higher levels of LacZ expression, measured 24 h postinfection, were obtained in the presence of 100 M EGTA.
These data indicate enhancement of transduction by low doses of EGTA both in vitro and in vivo. The mechanism underlying these effects may be independent or in conjunction with the disruption of tight junctions, since strong increases in gene transfer were demonstrated in vitro in nonconfluent airway epithelial cells grown on plastic, ie, under conditions where tight junctional complexes would be unlikely to play a significant role in refractoriness to gene delivery vectors. THT 940, 1900 University Blvd, Birmingham, AL 35233; e-mail: Sadis.Matalon@ccc.uab.edu cell phenotype. We have now modified the extracellular matrix to allow for co-cultures of AT-I and AT-II cells to better model communication in vivo. Abbreviations: CF ϭ cystic fibrosis; CFTR ϭ cystic fibrosis transmembrane conductance regulator; IL ϭ interleukin; IRF ϭ interferon regulatory factor; LPS ϭ lipopolysaccharide; RT-PCR ϭ reverse transcriptase-polymerase chain reaction R espiratory infections by the opportunistic pathogen Pseudomonas aeruginosa in immunocompromised patients or in patients with cystic fibrosis (CF) are the result of unique conditions that allow this Gram-negative bacterium to colonize the lung. This interaction between the pathogen and host leads to responses in both cells that ultimately lead to severe lung degeneration in individuals with CF. Recently, several new resources and technologies have become available to investigators, which should greatly accelerate our understanding of the mechanism of P aeruginosa pathogenesis, as well as of host defenses. Foremost among these are DNA microarrays, which allow transcriptional profiling of the partial or entire genetic repertoires of the pathogen and its host. A comprehensive compendium of expression profiles will serve in understanding the complex interplay between pathogen and host during respiratory infections.
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Use of Genomics in Infectious Disease
The term systems biology describes the recent shift from studying single genes at a time to a more global study of whole genomes. This focus change has been made possible by the recent advent of a number of highthroughput methods and technologies, and has significantly influenced the understanding of the complex interactions between living cells, particularly as it applies to the interaction of bacteria with their hosts. Whole genome sequencing projects have provided the key resources for experimental and in silico analysis of genetic repertoires related to disease. As of June 2001, 51 complete microbial genomes have been published, with significant emphasis on pathogens (http://www.ncbi.nlm.nih.gov/PMGifs/ Genomes/micr.html). Another impressive advance is the rapid buildup of genome sequences of higher organisms, including that of the human genome. 1,2 Thus, it is now possible to examine, in a truly global sense, the mechanisms employed by bacteria to cause disease in humans and at the same time identify pathways that are mobilized by the host to eliminate the infecting organism.
Infections of immunocompromised humans by pathogenic bacteria provide interesting models to study the mechanisms of defense and adaptation in both pathogen and host. When bacteria normally found in the environment encounter a mammalian host, they must adapt in order to survive against challenges such as the immune system and changes in the availability of certain nutrients. These adaptations include synthesis of a capsule to avoid phagocytosis, changes to the outer membrane protein profile such as phase variation, initiation of type III secretion systems to alter host signaling, and induction of systems required for uptake of limiting nutrients such as iron. These genome-wide changes are critical for invading pathogens to survive in a hostile environment.
P aeruginosa is a ubiquitous Gram-negative bacterium. It is a major nosocomial pathogen, infecting burn, cancer, and other compromised patients. One of the most prevalent infections occurs in individuals with CF, the most common inherited disease among whites. Although several different mutations can lead to CF, 70% of these patients have a three-base pair deletion in the CF transmembrane conductance regulator (CFTR) gene resulting in the disruption of the normal processing of the protein product. While the loss of CFTR function, which normally serves as a chloride channel in epithelial cells, can directly account for many symptoms and manifestations of CF, complications from the chronic colonization of the respiratory tract by particular opportunistic bacterial pathogens, predominantly P aeruginosa, is the single most important cause of morbidity and mortality in such patients. Several studies have provided clues to the basis for the susceptibility of individuals with mutant CFTR to bacterial colonization. Some intriguing results include the following: (1) impairment in the activity of bactericidal mechanisms in the respiratory tract due to the unique composition of the airway fluid, 3 (2) utilization of CFTR as a receptor for bacterial internalization by epithelial cells, 4 (3) altered signaling by epithelial cells to the host defenses following binding of bacteria, 5 and (4) influence of bacterial signaling pathways as they grow in biofilms within the respiratory tract. 6 These insights deepen our appreciation of the undoubtedly complex interplay of host and bacterial factors during the initial colonization process. However, these findings do not fully explain the basic paradox of this unusual respiratory disease: why do patients succumb to overwhelming colonization by a common environmental bacterium in spite of a functional immune system and a robust inflammatory response? We may be closer to answering this question by application of research tools that examine the global nature of host-pathogen interactions by monitoring the combined activities of the virulence factors produced by P aeruginosa and their impact on the different cell types that this pathogen encounters in the respiratory tract.
